Stereotactic Body Radiotherapy: Clinical Trials

119 trials of Stereotactic Body Radiotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 unknown, 28 completed, 26 recruiting, 12 active not recruiting. 57 Phase 2, 35 Not applicable, 16 Phase 1, 11 Phase 3, 5 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 257Unknown 18, Completed 15, Recruiting 9, Active not recruiting 4, Terminated 4, Withdrawn 4, Not yet recruiting 3
Not applicable35Completed 10, Recruiting 8, Unknown 8, Active not recruiting 5, Terminated 2, Not yet recruiting 1, Withdrawn 1
Phase 116Completed 5, Terminated 5, Unknown 2, Active not recruiting 1, Recruiting 1, Suspended 1, Withdrawn 1
Phase 311Recruiting 4, Unknown 4, Completed 2, Active not recruiting 1
Early Phase 15Withdrawn 2, Completed 1, Terminated 1, Unknown 1
Phase 41Completed 1

Follow Stereotactic Body Radiotherapy: new trials by email Literature Review of Stereotactic Body Radiotherapy trials Research Report on Stereotactic Body Radiotherapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC
Durvalumab 50 MG/1 ML Intravenous Solution, Etoposide Injection, Cisplatin - Extensive-stage Small-cell Lung Cancer
Phase 1SuspendedUniversity of Maryland, Baltimore502027-01-302026-09-14
SBRT Combined With Iparomlimab and Tuvonralimab (QL1706) and Bevacizumab for Hepatocellular Carcinoma
Stereotactic Body Radiotherapy, Bevacizumab, Iparomlimab and Tuvonralimab - Hepatocellular Carcinoma (HCC)
Phase 2Not yet recruitingPeking University Cancer Hospital & Institute332026-10-152026-10-20
A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer
Stereotactic body radiotherapy, Cemiplimab, Cemiplimab and Fianlimab - Bladder Urothelial Carcinoma
Phase 2WithdrawnMemorial Sloan Kettering Cancer Center2026-09-012026-09-03
PSMA PET-Staged Comprehensive Progression-Directed Radiotherapy for Limited Progression in Prostate Cancer
Comprehensive Progression-Directed Radiotherapy - Oligoprogressive Prostate Cancer, Metastatic Prostate Cancer
RecruitingAffidea Nu-med Center of Oncological DIagnostics and Therapy10002026-06-262026-09-17
Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLM
SBRT, PD-1 Antibody, H101 - CRC, Liver Metastasis Colon Cancer
Phase 2Not yet recruitingJun Huang1142026-06-012026-04-28
Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma
Stereotactic body radiotherapy, Defactinib, Avutometinib - Pancreatic Adenocarcinoma, Cancer of the Pancreas
Phase 2RecruitingWashington University School of Medicine362026-04-102026-04-15
Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial
furmonertinib, ablation, stereotactic body radiotherapy - Non-small Cell Lung Cancer
Phase 2Not yet recruitingShanghai Pulmonary Hospital, Shanghai, China452026-04-012026-04-08
Postoperative Edge (RapidArc) Stereotactic Body Radiotherapy for Spinal Metastases
Stereotactic Body Radiotherapy - Spinal Metastases, Metastatic Epidural Spinal Cord Compression
RecruitingTianjin Medical University Cancer Institute and Hospital502025-06-012026-09-03
Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases
Standard Conventional Radiotherapy, Stereotactic Body Radiotherapy - Cancer Metastatic
Phase 3RecruitingCanadian Cancer Trials Group2302025-03-072026-10-16
Cardiac RadiothErapy for VEntricular Tachycardia II
stereotactic radiotherapy ablation - Ventricular Tachycardia (VT)
RecruitingUniversitaire Ziekenhuizen KU Leuven502025-01-012026-04-29
STereotactic Body Radiotherapy (SBRT) for Oligoprogressive Breast Cancer
Stereotactic body radiotherapy - Metastatic Breast Cancer, Oligoprogression
Not applicableNot yet recruitingJuravinski Cancer Center362024-09-012024-07-08
Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer
Stereotactic Body Radiotherapy, second-line systemic therapy - Metastatic Non-Small Cell Lung Cancer, NSCLC Stage IV
Phase 3RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine1042024-09-012024-08-30
COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases
Irreversible electroporation, Stereotactic body radiotherapy - Colorectal Cancer, Liver Metastases
Phase 2 / Phase 3RecruitingAmsterdam UMC, location VUmc782024-08-202024-08-23
SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy
Niraparib oral capsule, SBRT - Ovarian Cancer Recurrent
Phase 2RecruitingInstitute of Cancer Research, United Kingdom422024-06-202026-07-13
Atezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular Carcinoma
Stereotactic body radiotherapy - Advanced Hepatocellular Carcinoma, Chemotherapy
Not applicableRecruitingYonsei University332024-05-282024-11-01
Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)
Stereotactic body radiotherapy, Sintilimab - Hepatocellular Carcinoma
Phase 2RecruitingSun Yat-sen University1402024-04-052024-11-18
Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401)
Stereotactic body radiotherapy, Adebrelimab, Lenvatinib - Hepatocellular Carcinoma
Phase 2RecruitingMian XI602024-03-102024-03-12
Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)
Image Guided Radiotherapy - Gynecologic Cancer, Radiotherapy Side Effect
RecruitingIRCCS San Raffaele10002024-02-152026-10-22
Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)
Stereotactic body radiotherapy, Adebrelimab - Prostate Cancer Metastatic, Castration-resistant Prostate Cancer
Phase 2UnknownFudan University302024-01-302024-02-20
Carbon Fiber Transpedicular Screws in Treatment of Spinal Metastatic Disease
Transpedicular spinal stabilization - carbon fibers-based implants, Transpedicular spinal stabilization - titanium implants, Stereotactic body radiotherapy - Metastatic Spinal Cord Compression, Metastasis Spine
Not applicableRecruitingCopernicus Memorial Hospital2262023-12-012025-12-16

Showing 20 of 119. Sign in to see all of them.

Conditions studied

Carcinoma, Hepatocellular (15)  ·  Carcinoma, Non-Small-Cell Lung (14)  ·  Prostatic Neoplasms (13)  ·  Pancreatic Neoplasms (9)  ·  Breast Neoplasms (8)  ·  Neoplasm Metastasis (7)  ·  Colorectal Neoplasms (5)  ·  Lung Neoplasms (5)  ·  Head and Neck Neoplasms (4)  ·  Lymphatic Metastasis (3)  ·  Nasopharyngeal Carcinoma (3)  ·  Spinal Cord Compression (3)  ·  Squamous Cell Carcinoma of Head and Neck (3)  ·  Urinary Bladder Neoplasms (3)  ·  Carcinoma, Renal Cell (2)

Sponsors

Memorial Sloan Kettering Cancer Center (4)  ·  Mercy Research (4)  ·  University Hospital, Ghent (4)  ·  Juravinski Cancer Center (3)  ·  Korea Cancer Center Hospital (3)  ·  Maria Sklodowska-Curie National Research Institute of Oncology (3)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (3)  ·  Stanford University (3)  ·  Sun Yat-sen University (3)  ·  Washington University School of Medicine (3)  ·  Amsterdam UMC, location VUmc (2)  ·  Case Comprehensive Cancer Center (2)  ·  Dana-Farber Cancer Institute (2)  ·  IRCCS San Raffaele (2)  ·  Institute of Cancer Research, United Kingdom (2)

Countries

United States (35)  ·  China (20)  ·  Canada (12)  ·  Belgium (8)  ·  South Korea (8)  ·  Italy (7)  ·  Poland (6)  ·  United Kingdom (6)  ·  Netherlands (5)  ·  France (4)  ·  Australia (3)  ·  Denmark (3)  ·  Switzerland (3)  ·  Germany (2)  ·  Singapore (2)

Top investigators

Mi-Sook Kim, MD, PhD (3)  ·  Mian Xi, MD (3)  ·  Daniel T Chang (2)  ·  Abdulmajeed Dayyat, MD (1)  ·  Albert Koong (1)  ·  Alex De Caluwe, MD (1)  ·  Alexander Chi, MD (1)  ·  Amol J. Ghia, MD (1)  ·  Amy Xu, MD, PhD (1)  ·  Anand Swaminath, MD,FRCPC (1)  ·  Andrew Oar (1)  ·  Arjun Sahgal (1)  ·  Ashish Saxena, MD (1)  ·  Aya Kamaya (1)  ·  Benny Dahl, MD (1)

Results publications

PMID 29366520, PMID 36529152, PMID 15183474, PMID 17706308, PMID 18374511, PMID 19056184, PMID 19880262, PMID 20009882, PMID 21514629, PMID 22266935, PMID 22270280, PMID 22543211, PMID 22590666, PMID 23176540, PMID 24101042, PMID 24890347, PMID 24985964, PMID 26634381, PMID 26696788, PMID 26961088, PMID 27044935, PMID 27104782, PMID 27339115, PMID 27339116, PMID 27626136, PMID 27626365, PMID 27871280, PMID 28065538, PMID 28137295, PMID 28296582, PMID 28938918, PMID 29240541, PMID 29543938, PMID 30207593, PMID 30355464, PMID 30558224, PMID 30612710, PMID 30867104, PMID 30935383, PMID 31150869, PMID 31227373, PMID 31377694, PMID 31484505, PMID 31821973, PMID 31908301, PMID 31971828, PMID 32043791, PMID 32162821, PMID 32716739, PMID 33002429

NIH funding

2016 (1), 2017 (1), P30CA043703 (1), P30CA138292 (1), U10CA180868 (1)